mRNA vaccine by UPenn scientists could manage bird flu outbreak Penn In the News The Hill mRNA vaccine by UPenn scientists could manage bird flu outbreak Researchers led by Scott Hensley of the Perelman School of Medicine have collaborated with Drew Weissman to develop an mRNA vaccine to treat the H5N1 avian flu. Penn Medicine creates human bird flu vaccine Penn In the News 6ABC.com Penn Medicine creates human bird flu vaccine Researchers at Penn Medicine have created a human bird flu vaccine using mRNA, the same platform as the COVID-19 vaccine. Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them. Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty is an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center. (Image: Courtesy of Penn Medicine News) Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty, an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center, and his team focus on improving immunotherapy for pancreatic cancer. ‘Dual target’ cell therapy appears to shrink brain tumors Image: iStock/Ildar Imashev ‘Dual target’ cell therapy appears to shrink brain tumors Early Penn Medicine trial results show that targeting two tumor-associated proteins in patients with recurrent glioblastoma may be a promising step toward developing cell therapies for solid tumors. The mRNA miracle workers Penn In the News CBS News The mRNA miracle workers Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines. Load More
Penn Medicine creates human bird flu vaccine Penn In the News 6ABC.com Penn Medicine creates human bird flu vaccine Researchers at Penn Medicine have created a human bird flu vaccine using mRNA, the same platform as the COVID-19 vaccine. Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them. Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty is an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center. (Image: Courtesy of Penn Medicine News) Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty, an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center, and his team focus on improving immunotherapy for pancreatic cancer. ‘Dual target’ cell therapy appears to shrink brain tumors Image: iStock/Ildar Imashev ‘Dual target’ cell therapy appears to shrink brain tumors Early Penn Medicine trial results show that targeting two tumor-associated proteins in patients with recurrent glioblastoma may be a promising step toward developing cell therapies for solid tumors. The mRNA miracle workers Penn In the News CBS News The mRNA miracle workers Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines. Load More
Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them. Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty is an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center. (Image: Courtesy of Penn Medicine News) Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty, an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center, and his team focus on improving immunotherapy for pancreatic cancer. ‘Dual target’ cell therapy appears to shrink brain tumors Image: iStock/Ildar Imashev ‘Dual target’ cell therapy appears to shrink brain tumors Early Penn Medicine trial results show that targeting two tumor-associated proteins in patients with recurrent glioblastoma may be a promising step toward developing cell therapies for solid tumors. The mRNA miracle workers Penn In the News CBS News The mRNA miracle workers Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines. Load More
Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn.
Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy.
Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles.
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.
Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty is an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center. (Image: Courtesy of Penn Medicine News) Mapping pancreatic cancer to improve immunotherapy Gregory L. Beatty, an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center, and his team focus on improving immunotherapy for pancreatic cancer.
‘Dual target’ cell therapy appears to shrink brain tumors Image: iStock/Ildar Imashev ‘Dual target’ cell therapy appears to shrink brain tumors Early Penn Medicine trial results show that targeting two tumor-associated proteins in patients with recurrent glioblastoma may be a promising step toward developing cell therapies for solid tumors.
The mRNA miracle workers Penn In the News CBS News The mRNA miracle workers Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.